Welcome to eBioscience. Tel: 888.999.1371 or 858.642.2058.  San Diego, California, USA.
View cart
Account
Ordering help
MSDS
Home BestProtocols™ Technical Support About Us Contact Us
Clinical Products Research Products Custom Products Weekly New Products

Choose language for TDS:
 

Carrier-Free Recombinant Human IFN-alpha1 (Interferon-alpha1, IFN-a1)

RUO: For Research Use Only
 
Contents: Carrier-Free Recombinant Human IFN-alpha1 (Interferon-alpha1, IFN-a1)
Catalog Number: 34-8318
Formulation: Sterile liquid; phosphate buffered saline, pH 7.2, 150 mM NaCl, with no carriers or preservatives. 0.22 µm filtered.
Storage Conditions: For greatest stability, keep concentration of primary stock at or above 10 µg/ml. For long term storage, aliquot into polypropylene vials (volumes of 20 µl or greater) and store at or below -80°C. Avoid repeated freeze/thaw cycles.
Handling Conditions: For best recovery, always quick-spin vial prior to opening. For dilution of current stock, always include carrier protein (1% BSA or 10% FBS) in the buffered saline diluent.
Source: E. coli expressed amino acids Cys 24-Asp 189 of mature human IFNα1 (accession # NM_024013).
Molecular Mass: The protein is not methionylated at the N-terminal and has a predicted molecular mass of 19,386. The DTT reduced protein migrates as a 21 kDa polypeptide on SDS-PAGE and the non-reduced protein migrates as a 16 kDa polypeptide due to intramolecular disulfides.
Purity: Greater than 98% as determined by SDS-PAGE
Endotoxin Level: Less than 0.01 ng/ug cytokine as determined by the LAL assay.
Bioactivity: The recombinant human IFN-α1 has been tested for inhibition of the cytopathic effect of EMC virus on A549 cells. The ED50 for this effect is typically below 0.3 ng/ml, corresponding to a specific activity of 3 x 106 U/mg.
 
Product Options
Cat. No. Size Price Add Qty to Cart
34-8318-82 100 ug
To view relevant pricing, please select your country and resume browsing.

34-8318-85 500 ug
Note: Several countries will continue to be supplied via distributors. Country specific prices may apply.
   
 

Available Formats
Cat. No.FormatExcite
(nm)
Emit
(nm)
Reported ApplicationsRegulatory Status
14-8318 Recombinant Human IFN-alpha1 (Interferon-alpha1, IFN-a1) N/A N/A BA RUO
34-8318 Carrier-Free Recombinant Human IFN-alpha1 (Interferon-alpha1, IFN-a1) N/A N/A BA RUO
39-8318 Single-Use ELISA RSG Standard Recombinant Human IFN-alpha1 N/A N/A ELISA std RUO
Flow Cytometry Product Notes:
Test Sizes: To accommodate multicolor flow cytometry, eBioscience is in the process of reducing test size volumes from 20 µl to 5 µl. Please check your antibody vial for the recommended test size.
Fluorochrome Replacements: eBioscience is in the process of replacing all Pacific Blue® and APC-Alexa Fluor® 750 conjugated products with eFluor™ 450 and APC-eFluor™ 780 conjugated products, respectively.
 
Description
Human IFN-α1 is a type I interferon previously known as B-cell interferon, leukocyte interferon, lymphoblast interferon, and pH2-stable interferon. IFN-α1 is one of at least 23 different known variants of IFN-α. The individual proteins have molecular masses between 19-26 kDa and consist of proteins with lengths of 156-166 and 172 amino acids. The IFN-α forms are produced by monocytes/macrophages, lymphoblastoid cells, fibroblasts, and other cell types following induction by viruses, nucleic acids, glucocorticoid hormones, and low-molecular weight substances (n-butyrate, 5-bromodeoxyuridine). Human IFN-α1 promotes antiviral, antiparasitic, and antiproliferative activities.
Applications Reported
For research use only, not for diagnostic or therapeutic use. Recombinant human IFN-α1 is biologically active.
Applications Tested
The recombinant human IFN-α1 has been tested for inhibition of the cytopathic effect of EMC virus on A549 cells. The ED50 for this effect is typically below 0.3 ng/ml, corresponding to a specific activity of 3 x 106 U/mg.
References
Nagai, T., et al. 2003. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J. Immunol. 171: 5233-43.

Home  |   Index  |   Site Map  |   FAQ  |   Terms & Conditions  |   Distributors  |   Careers  |   Contact Us
Copyright © 2000-2009 eBioscience, Inc.
For research use only unless indicated otherwise. Not for further distribution without written consent.